|
Therapy of B-Cell Acute Lymphoblastic Leukemia: An Evolving Landscape
Presented by Amir Fathi, MD, Associate Professor of Medicine at Harvard Medical School, this activity will highlight individualized treatment selection for patients with acute lymphoblastic leukemia (ALL), as well as recent efficacy and safety data for novel therapeutic strategies. Start the activity now.
STATEMENT OF NEED
Acute lymphoblastic leukemia (ALL) is a hematologic malignancy characterized by the proliferation of immature lymphoid cells throughout the bone marrow and blood (Rana... |
|
|
Improving Outcomes in Hodgkin Lymphoma
This in-depth discussion, presented by Louis Diehl, MD, Professor of Medicine at Duke University Medical School, will feature strategies for incorporating predictive and prognostic markers, recent efficacy and safety data, and adverse event management strategies into treatment selection for patients with Hodgkin lymphoma (HL). Start the activity now.
STATEMENT OF NEED
Hodgkin lymphoma (HL) is a rare malignancy of the lymph nodes and lymphatic system, with about 8,830 new cases diagnosed ... |
|
|
Updates in Myelodysplastic Syndromes: Improving Patient Outcomes
This activity, presented by Mikkael Sekeres, MD, Chief of the Division of Hematology at the University of Miami Health System, will focus on predictive and prognostic markers for myelodysplastic syndromes (MDS), emerging data on novel therapies, and strategies to optimize safety and tolerability for patients with this disease. Start the activity now.
STATEMENT OF NEED
Myelodysplastic syndromes (MDS) comprise a heterogeneous group ofmyeloid malignanciesthat derive from abnormal multipot... |
|
|
Video Viewpoint Strategy Session: New Insights Into Preventing and Managing Chemotherapy-Induced Neutropenia
Discover recent developments in the prevention, treatment, and management of chemotherapy-induced neutropenia, including a comprehensive understanding of the risk factors and current clinical practice guidelines. This activity is presented by Gary H. Lyman, MD, MPH, FASCO, FACP, FRCP, Professor, University of Washington, and Maura Abbott, PhD, AOCNP®, CPNP, Columbia University School of Nursing. Start the activity now.
STATEMENT OF NEED
Chemotherapy-induced neutropenia (CIN) is a potent... |
|
|
Podcast: New Insights Into Preventing and Managing Chemotherapy-Induced Neutropenia
Discover recent developments in the prevention, treatment, and management of chemotherapy-induced neutropenia, including a comprehensive understanding of the risk factors and current clinical practice guidelines. This activity is presented by Gary H. Lyman, MD, MPH, FASCO, FACP, FRCP, Professor, University of Washington, and Maura Abbott, PhD, AOCNP®, CPNP, Columbia University School of Nursing. Start the activity now.
STATEMENT OF NEED
Chemotherapy-induced neutropenia (CIN) is a potent... |
|
Keeping Up with Advances in MS: Cases in Diagnosis and Treatment, A Case-Based Roadmap for Improved Patient Outcomes in Multiple Sclerosis
Join Edward Fox, MD, PhD, and Matthew Schindler, MD, PhD, in an interactive case-based roadmap for improved outcomes in patients with MS. In addition to addressing diagnostic challenges, Drs. Fox and Schindler share their insights into integrating advances in the pharmacologic treatment of patients with MS, focusing on the safety and efficacy of targeted therapies. |
|
|
Managing Symptom Burden and Optimizing Treatment Outcomes in Myelofibrosis
Learn more about myelofibrosis risk factors, novel therapies to slow disease progression and reduce symptoms, and strategies to maintain quality of life in this comprehensive activity presented by John Mascarenhas, MD, Professor of Medicine at Mount Sinai Icahn School of Medicine. Start the activity now!
STATEMENT OF NEED
Myelofibrosis is a rare myeloproliferative neoplasm characterized by the buildup of scar tissue in the bone marrow, leading to decreased erythropoiesis, progressive bon... |
|
Paired Conversations: The Management of Patients With Hepatorenal Syndrome-Acute Kidney Injury: An International Perspective
This activity consists of 6 paired conversations with experts from Europe and the United States in the fields of hepatology, critical care, nephrology, and transplantation. During these paired conversations, the faculty explore revised diagnostic criteria, emerging treatment, and coordinating effective multidisciplinary care. In addition, the faculty panel collaboratively reviews a patient case where they share international perspectives on the nonpharmacological and pharmacological treatment ... |
|
|
Podcast: New Opportunities for Improved Patient Outcomes in Graft-Versus-Host-Disease
STATEMENT OF NEED
Graft-versus-host disease (GHVD) is a common complication of allogeneic hematopoietic stem cell transplant (HSCT) and a major contributor to morbidity and mortality (DeFilipp et al, 2021; Malard et al, 2020). Acute GVHD occurs within 100 days of transplant and typically targets the skin, gastrointestinal tract, and liver (LLS, 2022). Chronic GVHD often presents within the first year following HSCT but may develop in subsequent years. It most commonly affects the skin; howe... |
|
Expanding Cultural Competencies for Transgender and Transitioning Patients
Pharmacists lack the cultural competency training and pharmacological care in the transgender community.
This course is designed to increase awareness of the importance of transgender need in healthcare and to help pharmacists increase culturally competent in treating transitioning patients, including communication strategies. |
|
|
Sexual Harassment for Pharmacists - 2022 Update
Illinois law requires that health providers with professional licenses issued by the Illinois Department of Financial and Professional Regulation (IDFPR ) that require CE credits for renewal must complete 1 hour of CE on the topic of sexual harassment prevention training per licensure period.
Sexual harassment is a continuing concern in the workplace. Pharmacists should be knowledgeable enough to recognize sexual harassment, including the different types and what to do when they encoun... |
|
|
Immunization Administration Training for Pharmacists (with Virtual Assessment)
CEImpact is the first to offer an option for on-demand virtual assessment as part of their immunization training certificate course. This means the learner can complete the full certificate course by demonstrating their immunization technique one-on-one with a CEImpact trainer using a web-based meeting platform. Avoid costs associated with travel and time when you choose this option. This 20-hour, practice-based education course is intended for pharmacists and student pharmacists who are inter... |
|
|
Updates in Mantle Cell Lymphoma
Discover insights on predictive and prognostic markers, emerging efficacy and safety data, strategies to optimize tolerability for patients receiving novel therapies for mantle cell lymphoma (MCL), and more in this case-based activity presented by John Leonard, MD, the Richard T. Silver Distinguished Professor of Hematology and Medical Oncology at Weill Cornell Medicine. Start the activity now.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is an aggressive variant of B-cell non-Hodgkin ly... |
|
|
Treatment Advances in Waldenstrom Macroglobulinemia
In this case-based discussion, Morie Gertz, MD, Chair of General Internal Medicine at the Mayo Clinic in Minnesota, will discuss how to use predictive and prognostic markers to select treatment for patients with Waldenstrom macroglobulinemia (WM) and how to appraise emerging clinical trial data and adverse event management strategies for novel treatments. Start the activity now.
STATEMENT OF NEED
Waldenstrom macroglobulinemia (WM) is a rare cancer of B lymphocytes associated with lymphop... |
|
|
Sexual Harassment
Objectives
1. Define Sexual harassment, including its forms and types
2. Describe the two different types of sexual harassment
3. Explain how to handle sexual harassment experienced or witnessed in the workplace
4. Discuss the options available for reporting sexual harassment in the workplace
5. Describe state and federal protections against retaliation by employers (whistleblower protections) for reporting sexual harassment |
|
|
WEBINAR: Putting Science in Practice: New Concept to Get Paid for Pharmacy Services
The current payment paradigm for reimbursement of pharmacy services may soon play less of a role in the community pharmacist’s business model if it does not disappear completely. Monolithic organizations with logistical expertise are poised to enter the realm of community pharmacy practice and disrupt this model as they have in other retail worlds. What will be presented is a new method of delivering pharmacy services that provide value for the pharmacist and patient, create a deeper relatio... |
|
|
WEBINAR: Recognizing Cardiometabolic Syndrome in Community Pharmacy
Cardiometabolic syndrome (CMS) is a combination of metabolic dysfunctions mainly characterized by insulin resistance, impaired glucose tolerance, dyslipidemia, hypertension, and central adiposity. CMS is now recognized as a disease entity by the World Health Organization and the American Society of Endocrinology. Community pharmacists are in a perfect position to help guide patients through nutrition, supplement support and lifestyle modifications that are proven to produce improved outcomes. |
|
|
WEBINAR: An Overview of CBD in Pet Patients
After completing this activity, pharmacists and technicians will have a better understanding of using hemp derived CBD products in their animal patients. Pharmacists and technicians will be able to differentiate between the various formulations of products derived from hemp and understand what components help insure a quality CBD product.
|
|
|
WEBINAR: GFI #256 - Implications of the Next Round of FDA Compounding Guidance
Compounding with bulk chemicals (APIs) for animal patients has been in a regulatory void since November 2017 when FDA abruptly withdrew its compounding guidance and did not replace it. In November 2019, FDA released a draft of proposed guidance for Industry addressing how FDA intends to apply enforcement discretion to pharmacists and veterinarians using APIs to compound for animal patients. In that guidance, FDA identifies enforcement priorities and proposes various lists of APIs that may or m... |
|
|
WEBINAR: CBD and Drug Interactions - What Pharmacists Need To Know
Drug interactions have always been a complicated issue for health care providers. Since more than half of U.S. adults regularly take prescription medications and at least 75% of Americans take at least one over-the-counter product along with their prescription meds, the currently increasing use of CBD products makes the Pharmacists drug monitoring role even more difficult.
With each passing day, it becomes more important that all health care providers and especially Pharmacists, be prepared... |
|
|
Asthma Management: New Developments
Asthma is a chronic inflammatory disease that affects over 339 million individuals worldwide. Characterized by variable airflow limitation and bronchial hyperresponsiveness, symptoms include wheezing, shortness of breath, chest tightness, and/or cough. Asthma symptoms are episodic in nature, often worse at night or in the early morning, and can be triggered by factors such as exercise, airborne allergens, pollution, cigarette smoking, weather changes (eg, very cold, low humidity), and viral up... |
|
|
10-Night Great Barrier Reef CME AWAY® Cruise - Diabetes, Mood and Sleep Disorders, Osteoporosis, Thyroid Disease & Pain Management
Sydney, Australia • Eden, Australia • Airlie Beach, Qld, Australia • Cairns (Yorkey's Knob), Australia • Port Douglas, Australia • Willis Island (Cruising), Australia |
|
|
Right Treatment, Right Time: Case-Based Podcasts on MS Treatment PODCAST 4:MS DMTs and vaccines
Program Overview
This podcast reviews considerations for starting disease-modifying therapy for a patient recently diagnosed with relapsing MS.
Learning Objectives
Upon completion of this activity, participants should be better able to:
Examine relevant data for choosing an appropriate DMT based on patient-specific characteristics
Incorporate evidence-based benefit-risk assessment and utilize shared decision making in the development of individualized treatment plans |
|
|
Right Treatment, Right Time: Case-Based Podcasts on MS Treatment PODCAST 1: Newly Diagnosed Relapsing MS and Treatment Considerations
Program Overview
This podcast reviews considerations for starting disease-modifying therapy for a patient recently diagnosed with relapsing MS.
Learning Objectives
Upon completion of this activity, participants should be better able to:
Examine relevant data for choosing an appropriate DMT based on patient-specific characteristics
Incorporate evidence-based benefit-risk assessment and utilize shared decision making in the development of individualized treatment plans |
|
|
Multidisciplinary Viewpoints on NTM-LD Diagnosis and Management
In two virtual roundtables, a pulmonologist, infectious disease specialist, and clinical pharmacist share their experiences in addressing challenges in diagnosing and treating patients with NTM-LD. The expert panel discusses strategies for expediting diagnosis and improving patient care and outcomes within the context of a patient’s reflections on the path to diagnosis and their treatment experience. Through this approach, learners hear from a real-world patient as the multidisciplinary pane... |
|
|
A Comprehensive Review of Metastatic Colorectal Cancer (mCRC) Management: An Interprofessional Approach to Care
TARGET AUDIENCE:
This activity is designed to meet the educational needs of oncologists, oncology nurses and pharmacists engaged in the care of patients with metastatic colorectal cancer.
PROGRAM OVERVIEW:
This interprofessional activity will cover:
• Changes in treatment combinations and sequencing of regimens, as well as molecular markers that should be tested to guide therapy.
• Supportive care measures and continual monitoring based on their therapy to ensure optimal outcomes an... |
|
|
ForuMS: Highlights from the 2021 CMSC Annual Meeting
TARGET AUDIENCE:
This activity is designed to meet the educational needs of neurologists, primary care physicians, nurse practitioners, nurses, PAs, rehabilitation specialists, mental health specialists, radiologists, and other clinicians who are part of the team that manages patients with MS.
PROGRAM OVERVIEW:
This timely enduring activity is designed to review highlights from the 2021 CMSC annual meeting.
LEARNING OBJECTIVES:
Upon completion of this activity, participants should ... |
|
|
Right Treatment, Right Time: Case-Based Podcasts on MS Treatment - PODCAST 2: MS Symptom Management
Target Audience
This activity is designed to meet the educational needs of neurologists, advanced practice clinicians, nurses, pharmacists, and other members of the healthcare team caring for patients with MS.
Program Overview
This podcast dicusses strategies for managing some of the symptoms experienced by people living with MS.
Learning Objectives
Upon completion of this activity, participants should be better able to:
Incorporate evidence-based benefit-risk assessment and ... |
|
|
Right Treatment, Right Time: Case-Based Podcasts on MS Treatment PODCAST 3:Suboptimal Response to Treatment/Breakthrough Disease
Target Audience
This activity is designed to meet the educational needs of neurologists, advanced practice clinicians, nurses, pharmacists, and other members of the healthcare team caring for patients with MS.
Program Overview
This podcast dicusses the evaluation and management of breakthrough disease activity.
Learning Objectives
Upon completion of this activity, participants should be better able to:
Examine relevant data for choosing an appropriate DMT based on patient-spe... |
|
|
A Comprehensive Review of Metastatic Colorectal Cancer (mCRC) Management: An Interprofessional Approach to Care
Target Audience
This activity is designed to meet the educational needs of oncologists, oncology nurses and pharmacists engaged in the care of patients with metastatic colorectal cancer.
Program Overview
This activity will address changes in treatment combinations and sequencing of regimens, as well as molecular markers that should be tested to guide therapy. Further, supportive care measures and continual monitoring based on their therapy to ensure optimal outcomes and minimize adverse e... |
|
|
Fundamental Compounding with Pharmacy Law
March 9th - 11th, 2023
FUNDAMENTAL COMPOUNDING is an accredited 3-day course that combines a 20-hour (2.0 CEUs) practice-based course with a 1 hour (0.1 CEU) knowledge-based course in Fundamental Compounding Law.
This course is designed for pharmacists, technicians, and students who are new to compounding or who have had training in the past but want a refresher. Physicians and other healthcare professionals are also welcome to attend.
CONTENT
This course provides didactic and hands-... |
|
|
Cruising the Seychelles & Coastal Tanzania: Hot Topics in Medical, Dental & Public Health Issues
Luxury Expedition with Abercrombie & Kent on Le Jacques Cartier
March 11 – 24, 2023
Join PES on an unforgettable, luxury expedition cruise aboard the 148-guest Le Jacques Cartier with A&K’s renowned Expedition Team for 12 nights exploring coastal Tanzania and Seychelles, where idyllic beaches, lush emerald mountains, and UNESCO-protected wildlife reserves await!
CME/CE Lecture Seminars for Medical, Dental, Nursing and Allied Healthcare Professionals
This Seminar is planned for 14... |
|
|
APhA's Pharmacy-Based Immunization Delivery Certification Program
American Pharmacists Association’s
Pharmacy-Based Immunization Delivery Program
A Certificate Training Program
Nov 15, 17 & 19 (2 evenings of Zoom, 1 live in person, 1 hour practicum at WesternU by appointment)
(Participants MUST attend all dates above)
Hosted by: WesternU, College of Pharmacy
Faculty:
Jason Wong, BScPhm, PharmD, BCPS, BCGP
Assistant Professor
WesternU, College of Pharmacy
Hyma Gogineni, MS, PharmD, TTS
Associate Professor,
WesternU College of Pharm... |
|
|
New Drugs 2019
Intended Audience: Pharmacists
The number of new drugs approved each year has increased significantly since 1990. Various expedited approval pathways such as Orphan Drug Status designation, Accelerated Approval, Fast-Track, Priority Reviews, and the use of surrogate endpoints in studies have reduced the FDA review time from more than 3 years in 1983 to less than 1 year in 2017. In 2019, the FDA’s Center for Drug Evaluation and Research approved 48 novel drugs – a decline from 59 in 2018... |
|
|
Short Courses Podcast: Management Considerations for Older People Living with Multiple Sclerosis PODCAST 1: Treatment Considerations For Older Patients Living With MS
Program Overview
This podcast provides a general overview of considerations relevant to the care of older people living with multiple sclerosis.
Learning Objectives
Upon completion of this activity, participants should be better able to:
Identify common challenges and health concerns of older patients living with MS |
|
|
Spotlight on IRON CLAD: Clinical Review of IV Iron Replacement Therapy for Cancer-and Chemotherapy-Induced Anemia
This quick, comprehensive video will review the diagnosis and treatment of cancer- and chemotherapy-induced anemia (CIA). Expert faculty, Dr. Jeffrey Gilreath from University of Utah Hospitals and Clinics
will discusses the role of intravenous (IV) iron replacement monotherapy, including ferric carboxymaltose (FCM), recent clinical trial data supporting its benefit in treatment of CIA, and management of adverse events in patients receiving this therapy. |
|
|
Preceptor Mini-Series 1: Preceptor Pharm Tools
(See movie trailer below detailed description).
This is a 12 episode, knowledge-based, video series developed to provide educational pearls to preceptors who train pharmacy students or residents on experiential rotations. Each video episode is 5-8 minutes in length and builds upon the next. The series follows a young preceptor and two students through a 6 week clinical rotation at a hospital. The two students are polar opposites and present unique challenges to the preceptor. At moments ... |
|
|
Comprehensive Sterile Compounding
March 30 - April 1, 2023
COMPREHENSIVE STERILE COMPOUNDING is an accredited 3-day, 20-hour (2.0 CEUs) practice-based course designed for pharmacists and technicians who are experienced in compounding.
Physicians and other healthcare professionals are welcome to attend. This course will also provide initial aseptic training for pharmacists and technicians required by their state board of pharmacy in order to compound sterile preparations.
Participants are instructed in the proper asept... |
|
|
12-Night Japanese Cherry Blossom CME AWAY® Cruise - Updates in Neurology & Infectious Diseases
Tokyo (Yokohama), Japan • Aomori, Japan • Hakodate, Japan • Busan, South Korea • Hiroshima, Japan • Kobe, Japan • Kyoto (Osaka), Japan • Mt Fuji (Shimizu), Japan |
|
|
Management Considerations for Older People Living with Multiple Sclerosis PODCAST 2: Older MS Patients and Cognition
Target Audience
This activity is designed to meet the educational needs of neurologists, primary care physicians, nurse practitioners, PAs, nurses, pharmacists, mental health professionals, rehabilitation specialists, and other members of the healthcare team caring for patients with MS.
Program Overview
This episode involves a discussion of cognitive impairments and the challenges they may create in the care of older people with multiple sclerosis.
Learning Objectives
Upon compl... |
|
|
Management Considerations for Older People Living with Multiple Sclerosis PODCAST 3: Older MS Patients and Cardiovascular Disease
Target Audience
This activity is designed to meet the educational needs of neurologists, primary care physicians, nurse practitioners, PAs, nurses, pharmacists, mental health professionals, rehabilitation specialists, and other members of the healthcare team caring for patients with MS.
Program Overview
This podcast addresses comorbid cardiovascular diseases and risk factors in older people living with MS.
Learning Objectives
Upon completion of this activity, participants should... |
|
|
Management Considerations for Older People Living with Multiple Sclerosis PODCAST 4: Support Services and Resources For Older MS Patients
Target Audience
This activity is designed to meet the educational needs of neurologists, primary care physicians, nurse practitioners, PAs, nurses, pharmacists, mental health professionals, rehabilitation specialists, and other members of the healthcare team caring for patients with MS.
Program Overview
This podcast offers advice about useful resources and strategies for supporting older patients with multiple sclerosis and helping them cope with the combined challenges of aging and l... |
|
|
Telemedicine Talk Intensifying Weight Loss Efforts with Pharmacotherapy in Patients at High Risk for CV Complications
Target Audience
This activity has been designed for clinicians interested in the management of patients with obesity. Specialties include primary care providers, cardiologists, endocrinologists, obstetricians/gynecologists, and rheumatologists.
Program Overview
Obesity continues to become more prevalent in the United States, and with it, patients’ health and quality of life are diminished by increased incidence of conditions such as obstructive sleep apnea. The majority of clinician... |
|
|
Point of Care Testing: Assessment and Administration (Pharmacist)
This course is designed to provide frontline pharmacists with information to assess patients’ need for point of care tests, determine the appropriate test to administer, and collect nasal and throat specimens to determine the presence of Strep A, influenza, or COVID-19. Additional resources accompany this course, including guidance for blood pressure measurement, reusable form templates for gathering and documenting patient information, and a printable guide summarizing symptoms, testing cri... |
|
|
Point of Care Testing: Assessment and Administration (Technician)
This course is designed to provide frontline pharmacy teams with information to assess patients’ need for point of care tests, determine the appropriate test to administer, and collect nasal and throat specimens to determine the presence of Strep A, influenza, or COVID-19. Additional resources accompany this course, including guidance for blood pressure measurement, reusable form templates for gathering and documenting patient information, and a printable guide summarizing symptoms, testing ... |
|
|
Online CE/CME - New Drug Update 2020 Part 1
Earn 5 hours of ACPE or AAFP (AMA Category 2 credit) at the location of your choosing.
At the completion of this activity, the participant will be able to:
1. Identify recent FDA drug communications, including but not limited to, labeling changes, warnings, new indications, new dosage forms and MedWatch alerts.
2. Discuss the new drugs with respect to their pharmacology, pharmacokinetics, approved and unapproved indications.
3. Describe their adverse effects and drug interaction t... |
|
|
Online CE/CME - New Drug Update 2020 Part 2
Earn 5 hours of ACPE or AAFP (AMA Category 2 credit) at the location of your choosing.
At the completion of this activity, the participant will be able to:
1. Discuss the new drugs with respect to their pharmacology, pharmacokinetics, approved and unapproved indications.
2. Describe their adverse effects and drug interaction that may affect patient compliance.
3. Compare efficacy, dosage and cost to existing agents.
4. Discuss the patient oriented outcomes or evidence that may ... |
|
|
2020 Federal Pharmacy Law Update (Technician)
Numerous health issues continue on the agenda of the 116th Congress and within the federal agencies with impact upon a pharmacist’s practice and the profession. This session will provide an update on current federal legislative and regulatory activities pertaining to pharmacy. Efforts to create PBM transparency and solve reimbursement and drug pricing challenges, achieve support for pharmacist-provided clinical services, and other key legislation affecting the profession will be discussed. A... |
|
|
2020 Federal Pharmacy Law Update (Pharmacist)
Numerous health issues continue on the agenda of the 116th Congress and within the federal agencies with impact upon a pharmacist’s practice and the profession. This session will provide an update on current federal legislative and regulatory activities pertaining to pharmacy. Efforts to create PBM transparency and solve reimbursement and drug pricing challenges, achieve support for pharmacist-provided clinical services, and other key legislation affecting the profession will be discussed. A... |
|
|
Heart Failure
Intended Audience: Pharmacists
Heart failure (HF) is a common condition that causes significant disability and death in the US and around the world. About 6.5 million adults in the US have HF – and despite advances in drug and device therapies, HF was a contributing cause of 1 in 8 deaths in 2017.The estimated total cost of HF (including health care, medication and missed work) in 2012 was almost $31 billion.The prevalence of HF continues to rise, and is expected to exceed 8 million peopl... |
|